All Type of News
Foreign drug corporations to integrate sales and marketing divisions.
Most of foreign multinational drug corporations are going to reshuffle the organization as for the sales and marketing divisions to consolidate under the one umbrella, and this trend seems to give a strong impact also...
Zyprexa's restricted reimbursement is in dispute
The Ministry of Health and Welfare announced its restricted reimbursement plan on Zyprexa (olanzapine) to take effect on September 1, to this effect that that if other inexpensive drugs compared to Zyprexa are ineffec...
Liability insurance for medical mishap compulsorily required to subscribe.
In line of legislating the Medical Dispute Arbitration Act, the health and medical institutions including pharmacies and hospitals have obligation to subscribe the liability insurance for possible medical mishaps.
...
Iressa anti-cancer drug registered in Japan.
A new anti-cancer drug, Iressa originally developed by Astra Zeneca, has been registered in Japan as of Aug. 30 and its NHI price set at 7,216.10 yen per 250mg tablet.
It takes usually 1-2 years for any new drug t...
Provisions for SNU and national university hospital administration to reshuffle.
The revised provisions concerning the establishment and administration of Seoul National University and other national university hospitals passed through the National Assembly on Aug. 26 and now promulgated.
The r...
Reference Price System faced challenges all around.
Many civic groups and other relevant organizations like the KPhA and KMA rejected unanimously the current government's drug pricing policy "Reference Price System", claiming that it hampers providing better medical se...
Increase rates of drug price lag far behind consumer price index
The increase rates of drug prices have been extremely lower than that of the consumer price index (CPI) albeit medical services sector in the surging demands, a pharmaceutical organization said recently.
Acco...
Ads of leading pharmaceutical firms focuses on renowned OTC products in first half
The domestic leading drug makers have concentrated their heavy ads outlays to their renowned OTC brands in the first half of this year, amid more aggressive public campaigns since implementation of the ongoing...
Novo Nordisk to reshuffle company structures.
Novo Nordisk Korea (President: Jeffry James Whitehead) has reshuffle the company structures in order to strengthen their diabetic product market.
The marketing and sales divisions put under the one umbrella and di...
Choong-wae Pharm opens English training course for employees
Choong-wae Pharm is now implementing its own English training program for employees at Songpa Education Institute by recruiting Beverley Burnham-king, an U.S. native speaker, as a full-time employee
The English tr...
